Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
Toschi
L
L
Istituto Clinico Humanitas, Department of Oncology and Hematology, Rozzano, Italy.
Cappuzzo
F
F
Jänne
P A
PA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D009367:Neoplasm Staging; D011300:Preoperative Care; D011379:Prognosis; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents